Rx volume is skyrocketing

November 1999

Rx volume is skyrocketing...up 50% since 1992.

More new drugs...and more aging boomers will fuel the trend.

Pharmacists are already working as fast as they can...juggling dispensing and insurance hassles with patient care.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Rx volume is skyrocketing
Dermatology Zithromax for acne
Dermatology Kinerase, a new cosmetic cream for wrinkles
Multiple Sclerosis Procarin, the experimental treatment for multiple sclerosis
Osteoporosis Evista (raloxifene) is now approved to TREAT osteoporosis
Osteoporosis Actonel (risedronate) for osteoporosis
Diabetes More diabetics on intensive therapy will use insulin pumps
Diabetes no longer be able to get BEEF insulin
Breast Cancer Arimidex (anastrozole) is at least as effective as tamoxifen for advanced breast cancer
Breast Cancer Ellence (el-LENCE, epirubicin)
estrogen cream (Premarin) for recurrent nosebleeds
Infectious Diseases IV Synercid
Infectious Diseases treating depression caused by alpha-interferons
dipyridamole (Persantine, etc) with aspirin to prevent stroke
foods that contain soy to reduce the risk of heart disease
Pediatrics Head lice are becoming resistant to permethrin (Nix)
Pediatrics famotidine (Pepcid) for autism
Depression DHEA might be useful for depression
Practice taking their diarrhea vaccine, RotaShield, off the market